Trial Profile
Long term outcomes study of Rituximab from a retrospective cohort of patients with warm and cold antibody-mediated autoimmune hemolytic anemia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Apr 2015
Price :
$35
*
At a glance
- Drugs Rituximab (Primary)
- Indications Autoimmune haemolytic anaemia
- Focus Adverse reactions; Therapeutic Use
- 01 Apr 2015 New trial record